|
CYRX | Cryoport, Inc. |
|
|
CYRX | Cryoport, Inc. |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 1.22 |
| Leverage | 42.87% |
| Market Cap | $ 329.5m |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -114.4m |
| Margin | -51.91% |
Cryoport, Inc., a life sciences services company, provides temperature controlled logistics solutions in the Americas, Europe, the Middle East, Africa, and Asia Pacific. The company is headquartered in Brentwood, Tennessee.